Sign in Register

Indication

SIADH syndrome

SIADH syndrome (syndrome of inappropriate antidiuretic hormone secretion) is an endocrine and fluid-electrolyte disorder characterized by the unsuppressed, non-physiologic release of antidiuretic hormone or enhanced sensitivity of renal vasopressin receptors. Read more about SIADH syndrome

8 drugs 7 manufacturers

Drugs that treat it

Common SIADH syndrome therapies.

Showing 1–8 of 8 drugs

Sort

SAMSCA (tolvaptan)

ANTIDIURETIC HORMONE ANTAGONISTS·SIADH SYNDROME·+1

Otsuka Pharmaceutical Co., Ltd.

JYNARQUE (tolvaptan)

ANTIDIURETIC HORMONE ANTAGONISTS·SIADH SYNDROME·+1

Otsuka Pharmaceutical Co., Ltd.

TOLVAPTAN

ANTIDIURETIC HORMONE ANTAGONISTS·SIADH SYNDROME·+1

CAMBER PHARMACE

TOLVAPTAN

ANTIDIURETIC HORMONE ANTAGONISTS·SIADH SYNDROME·+1

PAR HEALTH USA,

TOLVAPTAN

ANTIDIURETIC HORMONE ANTAGONISTS·SIADH SYNDROME·+1

APOTEX CORP

TOLVAPTAN

ANTIDIURETIC HORMONE ANTAGONISTS·SIADH SYNDROME·+1

ASCEND LABORATO

TOLVAPTAN

ANTIDIURETIC HORMONE ANTAGONISTS·SIADH SYNDROME·+1

NOVADOZ PHARMAC

TOLVAPTAN

ANTIDIURETIC HORMONE ANTAGONISTS·SIADH SYNDROME·+1

NORTHSTAR RX LL

Filter & compare in the drug finder →Opens the drug finder with SIADH syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon

Coming soon

About SIADH syndrome.

SIADH syndrome (syndrome of inappropriate antidiuretic hormone secretion) is an endocrine and fluid-electrolyte disorder characterized by the unsuppressed, non-physiologic release of antidiuretic hormone or enhanced sensitivity of renal vasopressin receptors.

It predominantly impacts the renal and central nervous systems, frequently arising secondary to malignancies, pulmonary infections, intracranial pathologies, or various pharmacologic agents.

Pathophysiologically, excessive hormone activity promotes persistent water reabsorption in the renal collecting ducts, leading to impaired free water excretion, hyperconcentrated urine, and dilutional, euvolemic hypotonic hyponatremia.

Clinically, affected individuals are classically euvolemic without edema, but secondary cellular swelling and cerebral edema can cause symptoms ranging from headache, nausea, and lethargy to severe neurocognitive impairment, seizures, and coma.

nih.gov
SIADH syndrome (syndrome of inappropriate antidiuretic hormone secretion) is an endocrine and fluid-electrolyte disorder characterized by the unsuppressed, non-physiologic release of antidiuretic hormone or enhanced sensitivity of renal vasopressin receptors
nih.gov
SIADH syndrome (syndrome of inappropriate antidiuretic hormone secretion) is an endocrine and fluid-electrolyte disorder characterized by the unsuppressed, non-physiologic release of antidiuretic hormone or enhanced sensitivity of renal vasopressin receptors It predominantly impacts the renal and central nervous systems, frequently arising secondary to malignancies, pulmonary infections, intracranial pathologies, or various pharmacologic agents
nih.gov
It predominantly impacts the renal and central nervous systems, frequently arising secondary to malignancies, pulmonary infections, intracranial pathologies, or various pharmacologic agents
medlineplus.gov
Pathophysiologically, excessive hormone activity promotes persistent water reabsorption in the renal collecting ducts, leading to impaired free water excretion, hyperconcentrated urine, and dilutional, euvolemic hypotonic hyponatremia Clinically, affected individuals are classically euvolemic without edema, but secondary cellular swelling and cerebral edema can cause symptoms ranging from headache, nausea, and lethargy to severe neurocognitive impairment, seizures, and coma
nih.gov
Pathophysiologically, excessive hormone activity promotes persistent water reabsorption in the renal collecting ducts, leading to impaired free water excretion, hyperconcentrated urine, and dilutional, euvolemic hypotonic hyponatremia
nih.gov
Clinically, affected individuals are classically euvolemic without edema, but secondary cellular swelling and cerebral edema can cause symptoms ranging from headache, nausea, and lethargy to severe neurocognitive impairment, seizures, and coma
nih.gov
Clinically, affected individuals are classically euvolemic without edema, but secondary cellular swelling and cerebral edema can cause symptoms ranging from headache, nausea, and lethargy to severe neurocognitive impairment, seizures, and coma

Personalize your experience

Follow SIADH syndrome and get updates as they land.

Create a free account

Already a member? Sign in

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it